Biotech Co. Neurona Therapeutics Raises $120M
Clinical stage biotech company Neurona Therapeutics announced Thursday that it raised $120 million to advance the development of its lead treatment NRTX-1001 as well as other preclinical programs....To view the full article, register now.
Already a subscriber? Click here to view full article